Neoleukin Therapeutics, Inc.
NLTX · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$75 | -$58 | -$61 | -$33 |
| Dep. & Amort. | $3 | $3 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $9 | $12 | $6 |
| Change in WC | $0 | $1 | -$1 | $1 |
| Other Non-Cash | -$7 | -$0 | $0 | $0 |
| Operating Cash Flow | -$71 | -$46 | -$48 | -$25 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$3 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$198 | -$108 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $50 | $0 | $0 |
| Other Inv. Act. | $74 | $0 | $0 | $0 |
| Investing Cash Flow | -$125 | -$59 | -$3 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $72 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $184 | $0 | $1 | $77 |
| Financing Cash Flow | $184 | $0 | $1 | $77 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$12 | -$105 | -$50 | $50 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $149 | $143 | $193 | $143 |
| End Cash | $137 | $39 | $143 | $193 |
| Free Cash Flow | -$71 | -$47 | -$51 | -$27 |